|
2005 Conference Publication Quantitative analysis of serotonin levels in the murine brain following treatment with serotonin reuptake inhibitor drugsWilliams, S. M., Bryan-Lluka, L. J. and Pow, D. V. (2005). Quantitative analysis of serotonin levels in the murine brain following treatment with serotonin reuptake inhibitor drugs. 25th Annual Meeting of the Australian Neuroscience Society (ANS), Perth, Australia, 30 January - 2 February 2005. Australia: ANS. |
|
2005 Conference Publication Pharmacological and substituded cysteine accessibility method (SCAM) analysis of transmembrane domain 5 (TMD5) of the human noradrenaline transporterKhamu, T. and Lluka, L. J. (2005). Pharmacological and substituded cysteine accessibility method (SCAM) analysis of transmembrane domain 5 (TMD5) of the human noradrenaline transporter. The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) - Australiasian Pharmaceutical Science Association (APSA) joint Annual Scientific Meeting 2005, Hilton on the Park, Melbourne, Australia, 4-7 December, 2005. Melbourne, Australia: Australian Society of Clinical and Experimental Pharmacologists Pharmacologists and Toxicologists. |
|
2004 Journal Article Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT)Bryan-Lluka, Lesley J., Papacostas, Marisa H., Paczkowski, Filip A. and Wanstall, Janet C. (2004). Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT). British Journal of Pharmacology, 143 (1), 63-70. doi: 10.1038/sj.bjp.0705904 |
|
2004 Conference Publication What is the role of transmembrane domain 2 (TMD2) in noradrenaline transporter (NET) function?Sucic, S. and Lluka, L.J. (2004). What is the role of transmembrane domain 2 (TMD2) in noradrenaline transporter (NET) function?. 8th World Congress on Clinical Pharmacology & Therapeutics, Brisbane, Australia, 1-6 August 2004. Australia: Blackwell Publishing Asia Pty Ltd. |
|
2004 Journal Article Role of proline residues in the expression and function of the human noradrenaline transporterPaczkowski, FA and Bryan-Lluka, LJ (2004). Role of proline residues in the expression and function of the human noradrenaline transporter. Journal of Neurochemistry, 88 (1), 203-211. doi: 10.1046/j.1471-4159.2003.02149.x |
|
2004 Conference Publication How do nitric oxide donors regulate the function of transporters for serotonin and noradrenaline?Paczkowski, F. A., Wanstall, J. C. and Lluka, L.J. (2004). How do nitric oxide donors regulate the function of transporters for serotonin and noradrenaline?. 8th World Congress on Clinical Pharmacology & Therapeutics, Brisbane, Australia, 1-6 August 2004. Australia: Blackwell Publishing Asia Pty Ltd. |
|
2003 Journal Article χ-conopeptide MrIA partially overlaps desipramine and cocaine binding sites on the human norepinephrine transporterBryan-Lluka, Lesley J., Bonisch, Heinz and Lewis, Richard J. (2003). χ-conopeptide MrIA partially overlaps desipramine and cocaine binding sites on the human norepinephrine transporter. Journal of Biological Chemistry, 278 (41), 40324-40329. doi: 10.1074/jbc.M213101200 |
|
2003 Journal Article 5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive ratsAwabdy, Doreen, Bryan-Lluka, Lesley J. and Wanstall, Janet C. (2003). 5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats. European Journal of Pharmacology, 459 (1), 1-7. doi: 10.1016/S0014-2999(02)02734-6 |
|
2003 Conference Publication Evidence for different, but overlapping, binding sites on the human noradrenaline transporter (hNET) for substrates, antidepressants and cocainePaczkowski, F. A., Sucic, S. and Bryan-Lluka, L. J. (2003). Evidence for different, but overlapping, binding sites on the human noradrenaline transporter (hNET) for substrates, antidepressants and cocaine. Summer Meeting of the British Association for Psychopharmacology, Cambridge, England, 20-23 July 2003. Oxford, United Kingdom: Sage Productions. |
|
2003 Journal Article An evaluation of factors affecting computer-based learning in haemostasis: A cultural experienceOverfield, J.A. and Lluka, L.J. (2003). An evaluation of factors affecting computer-based learning in haemostasis: A cultural experience. Bioscience Education E-Journal, 1 (1), 1-9. |
|
2002 Journal Article The role of conserved CXXXRXG motif in the expression and function of the human norepinephrine transporterSucic, Sonja and Bryan-Lluka, Lesley J. (2002). The role of conserved CXXXRXG motif in the expression and function of the human norepinephrine transporter. Molecular Brain Research, 108 (1-2), 40-50. doi: 10.1016/S0169-328X(02)00512-0 |
|
2002 Journal Article Functional significance of a highly conserved glutamate residue of the human noradrenaline transportereSucic, Sonja, Paczkowski, Filip A., Runkel, Fabian, Bonisch, Heinz and Bryan-Lluka, Leslie J. (2002). Functional significance of a highly conserved glutamate residue of the human noradrenaline transportere. Journal of Neurochemistry, 81 (2), 344-354. doi: 10.1046/j.1471-4159.2002.00826.x |
|
2002 Journal Article Pharmacological properties of the naturally occurring Ala457Pro variant of the human norepinephrine transporterPaczkowski, Filip A., Bonisch, Heinz and Bryan-Lluka, Lesley J. (2002). Pharmacological properties of the naturally occurring Ala457Pro variant of the human norepinephrine transporter. Pharmacogenetics, 12 (2), 165-173. doi: 10.1097/00008571-200203000-00010 |
|
2002 Journal Article Amino Acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transportersPaczkowski, FA and Bryan-Lluka, LJ (2002). Amino Acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters. Naunyn-Schmiedeberg's Archives of Pharmacology, 365 (4), 312-317. doi: 10.1007/s00210-002-0528-z |
|
2001 Journal Article Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacologyPaczkowski, Filip A. and Bryan-Lluka, Lesley J. (2001). Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology. Molecular Brain Research, 97 (1), 32-42. doi: 10.1016/S0169-328X(01)00295-9 |
|
2001 Journal Article Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporterBryan-Lluka, Lesley J., Paczkowski, Filip A. and Bonisch, Heinz (2001). Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporter. Neuropharmacology, 40 (4), 607-617. doi: 10.1016/S0028-3908(00)00201-X |
|
2001 Conference Publication 5-hydroxytryptamine and platelet function in hypoxic pulmonary hypertensive rats: Studies on uptake and aggregationAwabdy, D., Bryan-Lluka, L. J. and Wanstall, J. C. (2001). 5-hydroxytryptamine and platelet function in hypoxic pulmonary hypertensive rats: Studies on uptake and aggregation. ASCEPT Annual Scientific Meeting, University of Otago, Dunedin, New Zealand, 3-5 December, 2001. Victoria, Australia: ASCEPT. |
|
2001 Conference Publication Regulation of the norepinephrine transporter (NET) and the serotonin transporter (SERT) by second messengers and hormonesBryan-Lluka, L. J., Dunner, E. M. and Papacostas, M. H. (2001). Regulation of the norepinephrine transporter (NET) and the serotonin transporter (SERT) by second messengers and hormones. 9th International Catecholamine Symposium, Kyoto, Japan/Kyoto International Conference Hall, 31 March - 5 April, 2001. Kyoto, Japan: |
|
2001 Conference Publication Similar effects of mutations in the first intracellular loop and fifth transmembrane domain of the human norepinephrine transporterPaczkowski, F. A., Sucic, S. and Bryan-Lluka, L. J. (2001). Similar effects of mutations in the first intracellular loop and fifth transmembrane domain of the human norepinephrine transporter. The 9th International Catecholamine Symposium, Kyoto, Japan/Kyoto International Conference Hall, 31 March - 5 April 2001. Kyoto, Japan: N/A. |
|
2001 Conference Publication A naturally occurring human noradrenaline transporter mutation in transmembrane domain 9 causes differential changes in noradrenaline and cocaine affinities Abstracts of the . .Bryan-Lluka, L. J., Bonisch, H. and Paczkowski, F. A. (2001). A naturally occurring human noradrenaline transporter mutation in transmembrane domain 9 causes differential changes in noradrenaline and cocaine affinities Abstracts of the . .. British Pharmacological Society Meeting, United Kingdom, 5-7 September, 2001. London, England: |
